A new antithrombotic agent, aspalatone, attenuated cardiotoxicity induced by doxorubicin in the mouse; possible involvement of antioxidant mechanism
Authors:
- 1 December 1996
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 60 (4-5) , PL75-PL82
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- The effect of aspalatone, a new antithrombotic agent, on the specific activity of antioxidant enzyme in the rat bloodArchives of Pharmacal Research, 1996
- Experimental thrombosis model induced by free radicals. Application to aspirin and other different substancesThrombosis Research, 1995
- Timing of treatment with ICRF-187 and its effect on chronic doxorubicin cardiotoxicityCancer Chemotherapy and Pharmacology, 1993
- Modulation of Glutathione and Glutathione Dependent Antioxidant Enzymes in Mouse Heart Following Doxorubicin TherapyFree Radical Research Communications, 1993
- PZ-51 (Ebselen) in vivo protection against Adriamycin-induced mouse cardiac and hepatic lipid peroxidation and toxicityBiochemical Pharmacology, 1992
- Biochemical determinants of adriamycin® toxicity in mouse liver, heart and intestineBiochemical Pharmacology, 1992
- Nonsteroidal Anti-Inflammatory Drug Use and Death from Peptic Ulcer in Elderly PersonsAnnals of Internal Medicine, 1988
- Regional Distribution of Glutathione Peroxidase in the Adult Rat BrainJournal of Neurochemistry, 1980
- [41] Preparation and assay of superioxide dismutases1978
- Adriamycin: The Role of Lipid Peroxidation in Cardiac Toxicity and Tumor ResponseScience, 1977